Dar Bioscience Inc (DARE) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Dar Bioscience Inc   (NASDAQ: DARE)

Dar Bioscience Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DARE Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) -70.57 % 70.91 % 65.43 % 46.08 %
Gross Margin (Q2 TTM) 36.2 % 71.7 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. - 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q2 MRQ) 305.07 % 21.45 % 18.99 % 20.49 %
EBITDA Margin (Q2 TTM) -416.52 % 25.15 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. - 47.09 % 31.38 % 23.41 %
Operating Margin (Q2 MRQ) -1582.53 % 17.27 % 16.58 % 16.05 %
Operating Margin (Q2 TTM) -826.19 % 20.33 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. - 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 13.66 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q2 TTM) -595.22 % 16.7 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.98 % 10.37 % 13.52 %
Net Margin (Q2 MRQ) -1590.42 % 10.09 % 8.15 % 11.42 %
Net Margin (Q2 TTM) -817.03 % 13.13 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. - 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Reportable Research and development services and royalty revenue
  Explore Reportable Research and development services and royalty revenue Segment  -